Stock PAX PAXMAN AB
Add to a list
To use this feature you must be a member
Log inSign up

All News Paxman AB

Equities

PAX

SE0009806284

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:47 2024-05-15 am EDT 		5-day change 1st Jan Change
40.8 SEK +1.24% Intraday chart for Paxman AB +6.53% +10.87%
Jan. 15 Paxman AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Paxman AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Paxman publishes the company’s annual report for 2023
AQ
The shareholders of PAXMAN AB (publ) (”the Company”) are hereby invited to attend the Annual General Meeting on Thursday 23 May 2024 at 12:00 CEST.
AQ
See Redeye's interview with CEO Richard Paxman
AQ
Record year for Paxman!
AQ
Paxman AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Paxman's CEO Richard Paxman in a company presentation at Stora Aktiedagen in Stockholm
AQ
See CEO Richard Paxman presents at Redeye Life Science Day 2023 – 23 November
AQ
See Redeye's interview with CEO Richard Paxman
AQ
PAXMAN publishes its interim report for Q3 2023
AQ
Paxman AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Richard Paxman OBE, CEO of Paxman, will join Redeye Life Science Day 2023
AQ
PAXMAN Announces that US Centers for Medicare and Medicaid Services (CMS) continues to support scalp cooling but decreases rate for 2024
AQ
PAXMAN Announces Palmetto GBA Approves First Local Coverage Determination for Scalp Cooling Therapy
AQ
PAXMAN Announces Palmetto GBA Approves First Local Coverage Determination for Scalp Cooling Therapy
CI
See Redeye's interview with CEO Richard Paxman
AQ
PAXMAN publishes its interim report for Q2 2023
AQ
Paxman AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
PAXMAN announces proposal for Local Coverage Determination of scalp cooling therapy
AQ
See Redeye's interview with CEO Richard Paxman
AQ
Press release from PAXMAN AB’s 2023 Annual General Meeting
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PAX Stock
  4. News Paxman AB
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW